Detailed Information on Publication Record
2020
RNF43 truncations trap CK1 to drive niche-independent self-renewal in cancer
SPIT, Maureen, Nicola FENDERICO, Ingrid JORDENS, Tomasz Witold RADASZKIEWICZ, Rik G. H. LINDEBOOM et. al.Basic information
Original name
RNF43 truncations trap CK1 to drive niche-independent self-renewal in cancer
Authors
SPIT, Maureen, Nicola FENDERICO, Ingrid JORDENS, Tomasz Witold RADASZKIEWICZ (616 Poland, belonging to the institution), Rik G. H. LINDEBOOM, Jeroen M. BUGTER, Alba CRISTOBAL, Lars OOTES, Max VAN OSCH, Eline JANSSEN, Kim E. BOONEKAMP, Kateřina HANÁKOVÁ (203 Czech Republic, belonging to the institution), David POTĚŠIL (203 Czech Republic, belonging to the institution), Zbyněk ZDRÁHAL (203 Czech Republic, belonging to the institution), Sylvia F. BOJ, Jan Paul MEDEMA, Vítězslav BRYJA (203 Czech Republic, belonging to the institution), Bon-Kyoung KOO, Michiel VERMEULEN and Madelon M. MAURICE
Edition
EMBO Journal, Hoboken (USA), Wiley, 2020, 0261-4189
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
10601 Cell biology
Country of publisher
United States of America
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 11.598
RIV identification code
RIV/00216224:14310/20:00114578
Organization unit
Faculty of Science
UT WoS
000557439600001
Keywords in English
cancer mutations; human colon organoids; PORCNinhibitors; RNF43; Wnt signaling
Tags
International impact, Reviewed
Změněno: 2/11/2024 20:31, Ing. Martina Blahová
Abstract
V originále
Wnt/beta-catenin signaling is a primary pathway for stem cell maintenance during tissue renewal and a frequent target for mutations in cancer. Impaired Wnt receptor endocytosis due to loss of the ubiquitin ligaseRNF43 gives rise to Wnt-hypersensitive tumors that are susceptible to anti-Wnt-based therapy. Contrary to this paradigm, we identify a class ofRNF43 truncating cancer mutations that induce beta-catenin-mediated transcription, despite exhibiting retained Wnt receptor downregulation. These mutations interfere with a ubiquitin-independent suppressor role of theRNF43 cytosolic tail that involves Casein kinase 1 (CK1) binding and phosphorylation. Mechanistically, truncatedRNF43 variants trapCK1 at the plasma membrane, thereby preventing beta-catenin turnover and propelling ligand-independent target gene transcription. Gene editing of human colon stem cells shows thatRNF43 truncations cooperate with p53 loss to drive a niche-independent program for self-renewal and proliferation. Moreover, theseRNF43 variants confer decreased sensitivity to anti-Wnt-based therapy. Our data demonstrate the relevance of studying patient-derived mutations for understanding disease mechanisms and improved applications of precision medicine.
Links
GX19-28347X, research and development project |
| ||
LQ1601, research and development project |
| ||
90127, large research infrastructures |
|